These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32240677)

  • 1. Computational strategies towards developing novel antimelanogenic agents.
    Unni PA; Lulu SS; Pillai GG
    Life Sci; 2020 Jun; 250():117602. PubMed ID: 32240677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies.
    Ali A; Ashraf Z; Rafiq M; Kumar A; Jabeen F; Lee GJ; Nazir F; Ahmed M; Rhee M; Choi EH
    Med Chem; 2019; 15(7):715-728. PubMed ID: 30892163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationship studies of mushroom tyrosinase inhibitors.
    Xue CB; Luo WC; Ding Q; Liu SZ; Gao XX
    J Comput Aided Mol Des; 2008 May; 22(5):299-309. PubMed ID: 18256890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity.
    Rosa GP; Palmeira A; Resende DISP; Almeida IF; Kane-Pagès A; Barreto MC; Sousa E; Pinto MMM
    Bioorg Med Chem; 2021 Jan; 29():115873. PubMed ID: 33242700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
    Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
    Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiosemicarbazones as inhibitors of tyrosinase enzyme.
    Soares MA; Almeida MA; Marins-Goulart C; Chaves OA; Echevarria A; de Oliveira MCC
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3546-3550. PubMed ID: 28583798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and QSAR analyses of aromatic heterocycle thiosemicarbazone analogues for finding novel tyrosinase inhibitors.
    Dong H; Liu J; Liu X; Yu Y; Cao S
    Bioorg Chem; 2017 Dec; 75():106-117. PubMed ID: 28926783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory properties of aromatic thiosemicarbazones on mushroom tyrosinase: Synthesis, kinetic studies, molecular docking and effectiveness in melanogenesis inhibition.
    Hałdys K; Goldeman W; Jewgiński M; Wolińska E; Anger N; Rossowska J; Latajka R
    Bioorg Chem; 2018 Dec; 81():577-586. PubMed ID: 30248509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N'-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors with Potentiate Anti-Melanogenesis Activities.
    Iraji A; Khoshneviszadeh M; Bakhshizadeh P; Edraki N; Khoshneviszadeh M
    Med Chem; 2020; 16(7):892-902. PubMed ID: 31339074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization and biological evaluation of paeonol thiosemicarbazone analogues as mushroom tyrosinase inhibitors.
    Zhu TH; Cao SW; Yu YY
    Int J Biol Macromol; 2013 Nov; 62():589-95. PubMed ID: 24120880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
    Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
    J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design and synthesis of 4-o-substituted phenylmethylenethiosemicarbazones as novel tyrosinase inhibitors.
    Yi W; Cao R; Chen Z; Yu L; Wen H; Yan Q; Ma L; Song H
    Chem Pharm Bull (Tokyo); 2010 May; 58(5):752-4. PubMed ID: 20460810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and anti-melanogenic effects of (E)-2-benzoyl-3-(substituted phenyl)acrylonitriles.
    Yun HY; Kim DH; Son S; Ullah S; Kim SJ; Kim YJ; Yoo JW; Jung Y; Chun P; Moon HR
    Drug Des Devel Ther; 2015; 9():4259-68. PubMed ID: 26347064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inhibitors of tyrosinase produced by the 4-substitution of TCT (П).
    Liu J; Li M; Yu Y; Cao S
    Int J Biol Macromol; 2017 Oct; 103():1096-1106. PubMed ID: 28501601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies.
    Bagherzadeh K; Shirgahi Talari F; Sharifi A; Ganjali MR; Saboury AA; Amanlou M
    J Biomol Struct Dyn; 2015; 33(3):487-501. PubMed ID: 24601849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting tyrosinase inhibition by 3D QSAR pharmacophore models and designing potential tyrosinase inhibitors from Traditional Chinese medicine database.
    Gao H
    Phytomedicine; 2018 Jan; 38():145-157. PubMed ID: 29425647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refinement of arylthiosemicarbazone pharmacophore in inhibition of mushroom tyrosinase.
    Yi W; Dubois C; Yahiaoui S; Haudecoeur R; Belle C; Song H; Hardré R; Réglier M; Boumendjel A
    Eur J Med Chem; 2011 Sep; 46(9):4330-5. PubMed ID: 21777998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
    Boissy RE; Visscher M; DeLong MA
    Exp Dermatol; 2005 Aug; 14(8):601-8. PubMed ID: 16026582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
    Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
    Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent low toxicity inhibition of human melanogenesis by novel indole-containing octapeptides.
    Ubeid AA; Do S; Nye C; Hantash BM
    Biochim Biophys Acta; 2012 Oct; 1820(10):1481-9. PubMed ID: 22609875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.